Capabilities
Our Digital Health group guides companies through the myriad considerations they encounter as the delivery of healthcare becomes increasingly digital.
As private equity investment in the Life Sciences and Healthcare industry continues to increase, our cohesive regulatory and transactional approach helps ensure success through each phase of investment.
We provide 360-degree support to companies that develop, manufacture and distribute products tailored specifically toward improving women’s health, from start-ups to global corporations.
Our Sunshine and State Law Compliance Group serves as a powerful industry advocate with respect to transparency laws for more than 100 members companies.
We established the Surprise Billing and Price Transparency Group to assist our clients in developing solutions to changes in healthcare transparency laws.
The K&S International Ad Hoc Group is a coalition of 20+ pharma and medical device companies that focuses on international transparency/disclosure laws targeting manufacturers.
August 21, 2025
Breaking Down The Proposed Hemp Bill
August 4, 2025
Congressional Crack Down on Hemp Loophole? Significant Changes Loom for Hemp Industry
July 23, 2025
The One Big Beautiful Bill Act Explained: A Detailed Review of Key Changes for the Healthcare Industry
August 26, 2025
David Hoskins, Former Lead Litigation Counsel for the Centers for Medicare & Medicaid Services, Joins King & Spalding
August 18, 2025
Cory Hohnbaum, Antonio Lewis and Corinne Nabors represent Boehringer Ingelheim in a Zantac-related jury trial in an Illinois state court